Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Algenol is a biotechnology company specializing in the commercialization of algae-based technologies for sustainable product manufacturing and carbon utilization. Founded in 2006, the company utilizes proprietary cyanobacteria and patented photobioreactor systems to convert carbon dioxide into ethanol and high-value specialty chemicals. While initially focused on the biofuels market, Algenol has expanded its portfolio to include natural colorants, proteins, and water purification services. The company's integrated platform provides cost-effective, carbon-negative solutions for the energy, food, and cosmetic industries. Algenol operates a significant research and manufacturing facility in Fort Myers, Florida, to support its global commercialization efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Algenol Biofuels.